Benzinga | Jul 30, 2020 04:05PM EDT

Ultragenyx Pharmaceutical Q2 EPS $0.41 Up From $(1.72) YoY, Sales $61.70M Up From $24.15M YoY

Ultragenyx Pharmaceutical (NASDAQ:RARE) reported quarterly earnings of $0.41 per share. This is a 123.84 percent increase over losses of $(1.72) per share from the same period last year. The company reported $61.70 million in sales this quarter. This is a 155.50 percent increase over sales of $24.15 million the same period last year.